webinar register page

Webinar: CTX-009 - An Investigational Drug and How it May Help
Compass Therapeutics, CEO, Dr. Thomas J. Schuetz will share what CTX-009 is, how this investigational drug works, and how he and the company see it being utilized to help patients diagnosed with Cholangiocarcinoma. Dr. Schuetz will discuss drug development, how CTX-009 works, and the interim data from the ongoing phase 1b/2 study.

Aug 11, 2022 02:00 PM in Mountain Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Cholangiocarcinoma Foundation.